Article Versions Notes

Wang Y, Li Y, Cao J, Meng Q, Li X, Zhang Y, Lam KS, Hong A, Liu R, Chen X. Development and Characterization of a Novel Peptide—Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors. Biomedicines. 2021; 9(8):849. https://doi.org/10.3390/biomedicines9080849

Wang, Yayu, Yadan Li, Jieqiong Cao, Qilin Meng, Xiaocen Li, Yibo Zhang, Kit S. Lam, An Hong, Ruiwu Liu, and Xiaojia Chen. 2021. "Development and Characterization of a Novel Peptide—Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors" Biomedicines 9, no. 8: 849. https://doi.org/10.3390/biomedicines9080849

Wang, Y., Li, Y., Cao, J., Meng, Q., Li, X., Zhang, Y., Lam, K. S., Hong, A., Liu, R., & Chen, X. (2021). Development and Characterization of a Novel Peptide—Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors. Biomedicines, 9(8), 849. https://doi.org/10.3390/biomedicines9080849